Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001362310-08-001698
Filing Date
2008-03-31
Accepted
2008-03-31 16:24:32
Documents
8
Period of Report
2007-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K c72794e10vk.htm 10-K 824777
2 EXHIBIT 10.32 c72794exv10w32.htm EX-10.32 316520
3 EXHIBIT 23.1 c72794exv23w1.htm EX-23.1 1685
4 EXHIBIT 31.1 c72794exv31w1.htm EX-31.1 6109
5 EXHIBIT 31.2 c72794exv31w2.htm EX-31.2 6056
6 EXHIBIT 32.1 c72794exv32w1.htm EX-32.1 3666
7 EXHIBIT 32.2 c72794exv32w2.htm EX-32.2 3619
8 GRAPHIC c72794c7279401.gif GRAPHIC 43349
  Complete submission text file 0001362310-08-001698.txt   1223737
Mailing Address 1730 EAST RIVER ROAD SUITE 200 TUSCON AZ 85718
Business Address 1730 EAST RIVER ROAD SUITE 200 TUSCON AZ 85718 520-770-1259
IMARX THERAPEUTICS INC (Filer) CIK: 0001123695 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-33043 | Film No.: 08724983
SIC: 2834 Pharmaceutical Preparations